Research chemicals marketed as legal highs: the case of pipradrol derivatives.

  title={Research chemicals marketed as legal highs: the case of pipradrol derivatives.},
  author={M. Coppola and R. Mondola},
  journal={Toxicology letters},
  volume={212 1},
  • M. Coppola, R. Mondola
  • Published 2012
  • Medicine
  • Toxicology letters
  • Between 1997 and 2011, more than 200 new substances were notified through the early-warning system, with the record number of 49 novel molecules reported in 2011. The pattern of acute toxicity associated with the consumption of these new substances is generally similar to that seen with traditional drugs of abuse. Recently, a new class of synthetic stimulants closely related to pyrrolidine and piperidine compounds and known as pipradrol derivatives appeared in the recreational drug market… CONTINUE READING
    23 Citations
    Is the 5-iodo-2-aminoindan (5-IAI) the New MDMA?
    • 3
    Pipradrol and Pipradrol Derivatives
    • 3
    Four fatalities involving 5-IT.
    • 30
    • PDF
    Drugs of Abuse and the Internet
    • 3
    Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives.
    • 66
    • PDF


    Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol [D2PM])
    • 34
    • PDF
    Drugs for youth via Internet and the example of mephedrone.
    • 173
    • PDF
    "Legal highs" - new players in the old drama.
    • J. Zawilska
    • Psychology, Medicine
    • Current drug abuse reviews
    • 2011
    • 58
    Detecting novel and emerging recreational drugs on the 'club scene'
    • 16
    Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.
    • 74
    • PDF
    Desoxypipradrol is more potent than cocaine on evoked dopamine efflux in the nucleus accumbens
    • 31